Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heartburn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06552624
What this trial is testing

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Who this might be right for
HeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers
Valenta Pharm JSC 40
Not applicableStudy completedNCT06094062
What this trial is testing

Smartphone App-assisted PPI

Who this might be right for
HeartburnDyspepsia
University Hospital, Basel, Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT01472939
What this trial is testing

Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease
Shire 480
Not applicableStudy completedNCT06889246
What this trial is testing

The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux Disease

Who this might be right for
GERD (Heartburn, Regurgitation, and Dyspepsia) FrequencyGERD (Heartburn, Regurgitation, and Dyspepsia) Severity
Haiphong University of Medicine and Pharmacy 27
Testing effectiveness (Phase 2)Study completedNCT04799158
What this trial is testing

Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Who this might be right for
Non-Erosive Gastro-Esophageal Reflux DiseaseHeartburn
Phathom Pharmaceuticals, Inc. 458
Early research (Phase 1)Study completedNCT00738842
What this trial is testing

Uric Acid Study in Healthy Male Volunteers

Who this might be right for
GoutCoronary Artery Disease
AstraZeneca 24
Post-approval studies (Phase 4)Study completedNCT01397084
What this trial is testing

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Who this might be right for
Gastroesophageal Reflux DiseaseGERDReflux Esophagitis
AstraZeneca 107
Large-scale testing (Phase 3)Study completedNCT00236197
What this trial is testing

E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

Who this might be right for
Heartburn
Eisai Inc. 619
Not applicableStudy completedNCT01601379
What this trial is testing

Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.

Who this might be right for
Gastroesophageal Reflux DiseaseGastro-oesophageal RefluxGastro-Esophageal Reflux+2 more
Janssen-Cilag International NV 7,964
Post-approval studies (Phase 4)Study completedNCT02689999
What this trial is testing

The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Neutec Ar-Ge San ve Tic A.Ş 12
Post-approval studies (Phase 4)Ended earlyNCT01404832
What this trial is testing

The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors

Who this might be right for
Gastroesophageal Reflux DiseaseEosinophilic Esophagitis
Dallas VA Medical Center 102
Post-approval studies (Phase 4)Study completedNCT00410592
What this trial is testing

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 90
Not applicableStudy completedNCT00481949
What this trial is testing

Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo

Who this might be right for
HeartburnGastro-esophageal Reflux
Guy's and St Thomas' NHS Foundation Trust 50
Early research (Phase 1)Study completedNCT01337804
What this trial is testing

Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

Who this might be right for
Heartburn
Bayer 50
Post-approval studies (Phase 4)UnknownNCT03467438
What this trial is testing

Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux Disease
Fondazione IRCCS Policlinico San Matteo di Pavia 80
Not applicableEnrolling By InvitationNCT07707011
What this trial is testing

Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms

Who this might be right for
GERD, Acid Reflux, Treatment
Mahidol University 120
Testing effectiveness (Phase 2)Study completedNCT01059383
What this trial is testing

Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

Who this might be right for
Gastroesophageal Reflux
Vecta Ltd. 52
Large-scale testing (Phase 3)UnknownNCT01128582
What this trial is testing

Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.

Who this might be right for
Gastroesophageal Reflux DiseaseChronic Insomnia
Southern Arizona VA Health Care System 40
Large-scale testing (Phase 3)Study completedNCT00171457
What this trial is testing

The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.

Who this might be right for
HeartburnDyspepsia
Novartis 24
Post-approval studies (Phase 4)Study completedNCT00734097
What this trial is testing

Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 314
Next Page